Revvity Inc vs Energy Select Sector SPDR Fund — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while Energy Select Sector SPDR Fund trades at $61.04. The key difference: Revvity Inc pays a 0.24% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| RVTY | XLE | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | — |
52-Week High | $117.75 | $62.57 |
52-Week Low | $82.26 | $42.33 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
XLE trades at $61.03, up 1.4% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights a 40.52% 12-month rally driven by strong oil prices and geopolitical tensions, though Seeking Alpha rates it HOLD due to less attractive entry points. The ETF's performance is heavily influenced by top holdings like ExxonMobil and Chevron, which reported surging Q2 profits.
Outlook remains tied to oil price volatility and Middle East tensions, offering growth potential but with high sensitivity to supply disruptions. Risks include geopolitical instability and concentrated exposure to a few large-cap energy stocks, warranting caution despite bullish momentum.
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →